Skip to content
Search

Latest Stories

Prescription charges in England frozen for the first time since 2010

Prescription charges have been frozen in England for the first time since 2010 due to what is said to be a "consideration of the cost of living crisis".

Patients needing NHS prescriptions will continue to pay £9.35 for each medicine or medical appliance dispensed, the Department of Health and Social Care (DHSC) has confirmed.


Last April saw the price of a prescription rise by 20p and there were widespread concerns that it would rise again this year. But health minister Edward Argar has confirmed that currently there were no plans to "uplift" the cost.

Responding to the DHSC announcement, RPS England chair Thorrun Govind said: “With continued pressures on teams, pharmacists should be allowed to focus on treating patients and prescriptions should not just be affordable, but they should be accessible to all.

“It is extraordinary that the government is considering forcing the over 60s to start paying prescription charges," she commented in relation to the proposals that would raise the age of free prescriptions to 66 -- in line with the state pension age.

Currently over 60s do not need to pay for their prescription while NHS prescriptions are free for everybody in Scotland, Wales and Northern Ireland.

"With the cost of living impacting all of Great Britain, the government should abolish prescription charges in England all together," Thorrun added.

Meanwhile, costs for the prescription prepayment certificate (PPC) also remain the same with £30.25 for three months and £108.10 for a year.

More For You

RPS Wales calls for urgent investment in pharmacy workforce at Senedd meeting

Third from the left: Eluned Morgan, First Minister of Wales

Photo credit: RPS

Invest in pharmacy workforce: RPS Wales urges Senedd members

Members of the Senedd (MSs) were briefed on the increasing pressures facing pharmacy teams and the urgent need for action to support their health and wellbeing at an event hosted by the Royal Pharmaceutical Society (RPS) Wales.

The event, held on Wednesday, brought together MSs, including first minister Eluned Morgan, to discuss the findings of RPS’ latest Workforce Wellbeing Survey.

Keep ReadingShow less
Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less
Henry Gregg named as new NPA chief executive

Henry Gregg (left) with Sir Chris Whitty

Pic credit: Henry Gregg/X

Henry Gregg named as new NPA chief executive

The National Pharmacy Association (NPA) has announced Henry Gregg will be the organisation’s new chief executive from May.

Gregg, who is currently director of external affairs at Asthma + Lung UK, replaces Paul Rees who departed in January.

Keep ReadingShow less
Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform

GP Connect Access Record will make a patient’s relevant medical information available to pharmacy.

Getty Images

Cegedim Rx activates GP Connect Access Record

Community pharmacy IT supplier Cegedim Rx has made GP Connect Access Record functionality available across its clinical services platform, providing registered pharmacy professionals with enhanced access to patient medical information.

The new feature, now live on Cegedim Rx’s Pharmacy Services platform, allows community pharmacies to retrieve relevant medical data when delivering NHS clinical services.

Keep ReadingShow less
Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

Patients who purchase two prescriptions per month could save more than £110 annually with a 12-month PPC.

Getty Images

Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

The NHS Business Services Authority (NHSBSA) has published a new experimental analysis, estimating patient savings achieved from prescription prepayment certificates (PPCs), including Hormone Replacement Therapy (HRT) PPCs.

The report revealed that the number of Prescription Prepayment Certificates (PPCs) purchased has risen consistently over the past five years, with 3.3 million patients receiving NHS prescriptions under a PPC exemption in 2023/2024.

Keep ReadingShow less